Accelerate diagnostics, inc. (AXDX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Oct'12Sep'12Jun'12Apr'12Mar'12Jan'12Dec'11Oct'11Jul'11Apr'11Jan'11Oct'10
Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Technical development fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

-

-140

-107

-214

-310

-210

Licensing and royalty revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16

19

14

79

16

13

14

12

13

7

16

12

2

5

22

13

9

8

189

12

-6

25

3

11

Net sales

2,342

3,470

2,271

1,806

1,750

1,822

1,355

1,692

801

2,120

828

699

530

39

24

20

163

22

92

19

14

79

16

13

14

12

13

7

16

12

8

5

22

13

9

8

-0

202

100

240

313

466

License fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

-

-50

0

0

0

0

Qualified discovery therapeutic grant

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

-

0

-

0

-

0

0

0

0

244

Cost of sales

1,287

1,957

1,117

907

916

1,298

680

717

492

650

191

135

26

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross profit

1,055

1,513

1,154

899

834

524

675

975

309

1,470

637

564

504

39

24

20

163

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Research and development

5,842

6,199

6,064

6,149

6,933

6,905

7,891

6,060

6,782

6,135

6,351

5,527

4,288

5,590

7,874

8,425

7,675

7,787

6,499

7,126

5,730

5,451

5,949

4,562

3,564

3,675

2,655

2,461

1,882

1,576

564

200

104

109

98

88

58

104

109

126

107

111

Sales, general and administrative

12,943

13,583

12,743

12,837

12,723

13,378

12,153

15,330

14,353

11,471

11,601

11,460

10,526

10,473

9,566

9,484

7,660

6,600

4,332

4,755

2,867

2,579

2,625

3,447

2,044

1,397

1,052

1,234

629

-365

754

1,632

998

248

162

198

103

458

212

181

189

235

Amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

3

2

15

18

19

19

20

19

19

19

27

25

10

64

64

64

64

-0

64

63

63

63

63

Marketing and sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

-

-

0

1

0

-

4

-

1

0

5

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

465

403

326

282

251

150

134

95

84

71

36

4

1

0

0

0

0

0

0

0

0

0

0

0

Impairment of intangibles

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

333

-

-

-

-

-

0

0

-

-

-

-

Total costs and expenses

18,785

19,782

18,807

18,986

19,656

20,283

20,044

21,390

21,135

17,606

17,952

16,987

14,814

16,063

17,440

17,909

15,335

13,185

11,299

12,287

8,925

8,330

8,843

8,178

5,761

5,198

3,810

3,785

2,566

1,575

1,685

1,844

1,168

423

326

351

158

631

378

374

361

416

Loss from operations

-17,730

-18,269

-17,653

-18,087

-18,822

-19,759

-19,369

-20,415

-20,826

-16,136

-17,315

-16,423

-14,310

-16,024

-17,416

-17,889

-15,172

-13,163

-11,207

-12,268

-8,911

-8,251

-8,827

-8,165

-5,747

-5,186

-3,797

-3,778

-2,550

-1,562

-1,676

-1,839

-1,145

-410

-317

-343

-158

-429

-277

-133

-47

49

Other income (expense):
Interest expense

3,749

-24,841

3,598

3,528

3,459

-16,833

3,357

3,205

158

0

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency exchange loss

-128

18

-89

6

-59

-119

-133

-253

55

-2

-40

-7

-26

38

-42

-117

44

-20

1

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

380

479

676

812

842

862

908

774

301

296

323

153

136

141

159

140

54

20

21

18

15

15

15

16

18

-

9

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

-

-3

0

-

-9

1

-

-2,001

-

2,001

0

-

-

-

-

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

2

-

110

-

117

23

98

0

21

16

14

13

13

13

18

-

-

-

1

-2

1

4

4

4

2

3

-3

4

4

4

3

3

Other expense, net

82

2

9

1

2

3

0

25

0

-

-

5

-

-

-

-

-

-

-

-

-

-

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expense, net

-3,579

-3,176

-3,020

-2,711

-2,678

-2,653

-2,582

-2,709

198

-

285

141

-

-

-

-

-

-

-1

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss before income taxes

-21,300

-21,416

-20,700

-20,800

-21,500

-22,412

-21,951

-23,124

-20,628

-16,023

-17,030

-16,282

-14,200

-

-17,299

-17,866

-

-

-

-

-

-

-

-

-

-15,284

0

1

1

-

11

-1,997

21

21

17

20

-

-0

-17

9

21

17

Unrealized holding gain on asset sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

-

-

Gain on sale of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

-

-

-

0

-

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,814

-8,152

-5,729

-

-3,797

-3,777

-2,549

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for income taxes

0

-149

-200

17

221

-221

147

101

184

273

45

175

0

-

0

0

-

-

-

-

-

-527

0

0

527

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-21,309

-21,335

-20,434

-20,815

-21,721

-22,191

-22,098

-23,225

-20,812

-16,296

-17,075

-16,457

-14,200

-16,135

-17,299

-17,866

-15,074

-13,163

-11,186

-12,252

-8,897

-8,765

-8,814

-8,152

-5,202

-5,159

-3,797

-3,777

-2,549

436

-1,665

-3,836

-1,123

-388

-299

-323

-156

-430

-295

-123

-26

67

Basic and diluted net loss per share (usd per share)

-0.39

-0.40

-0.37

-0.38

-0.40

-0.41

-0.41

-0.43

-0.37

-0.29

-0.31

-0.31

-0.27

-0.31

-0.34

-0.35

-0.29

-0.29

-0.25

-0.27

-0.20

-0.20

-0.20

-0.19

-0.12

-0.12

-0.10

-0.10

-0.09

0.02

-0.07

-0.15

-0.09

-0.03

-0.03

-0.03

-0.01

-0.04

-0.04

-0.01

0.00

0.01

Weighted average shares outstanding (shares)

54,837

54,658

54,553

54,476

54,337

54,188

54,145

54,003

55,640

55,521

55,316

53,568

51,887

51,456

51,239

51,213

51,196

45,937

44,727

44,678

44,650

174,374

44

43

41

150,288

39

38

29

25,703

25,261

25,004

11,776

11,103

11,103

11,103

11,160

11,103

10,946

10,704

10,757

10,757

Other comprehensive loss:
Net loss

-21,309

-21,335

-20,434

-20,815

-21,721

-22,191

-22,098

-23,225

-20,812

-16,296

-17,075

-16,457

-14,200

-16,135

-17,299

-17,866

-15,074

-13,163

-11,186

-12,252

-8,897

-8,765

-8,814

-8,152

-5,202

-5,159

-3,797

-3,777

-2,549

436

-1,665

-3,836

-1,123

-388

-299

-323

-156

-430

-295

-123

-26

67

Net unrealized gain on debt securities available-for-sale

223

-36

10

98

121

77

1

-2

-53

-124

-7

3

11

-75

-70

29

52

-16

-1

-8

5

-4

-17

2

4

11

11

0

0

0

10

0

17

17

15

15

4

-4

-36

5

17

13

Foreign currency translation adjustment

-15

37

-113

50

-76

-67

-26

-191

112

-30

91

204

56

-120

-8

49

-49

3

-2

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-21,101

-21,334

-20,537

-20,667

-21,676

-22,181

-22,123

-23,418

-20,753

-16,450

-16,991

-16,250

-14,133

-16,330

-17,377

-17,788

-15,071

-13,176

-11,189

-12,260

-8,892

-8,769

-8,831

-8,150

-5,198

-5,148

-3,786

-3,777

-2,549

436

-

-3,836

-

-

-

-

-

-

-

-

-

-